Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? Reviews in Endocrine and Metabolic Disorders Springer Nature Link Now that oral semaglutide (#wegovy) is available, people want to know more about how the oral and injectable forms compare. First slide is the trial design. Second slide is average #weightloss of